Interesting news and PAA obviously have a long and fruitful working relationship with ONJCRI.
Quite frankly the positivity of the science over a number of years as evident from various independent institutes/bodies is absolutely overwhelming but adds to the frustration of what appears to be lack of progress through the clinical trial phases.
As I believe PAA and its "wonder" drug MPL have achieved a major milestone and as such turned the corner with the recent ONJCRI announcement I am holding on tight for the day when the PAA SP explodes...just opining for the sake of it!!!
Ann: ONJCRI Evaluates Monepantel Anti-Cancer Mechanism, page-90
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.3¢ |
Change
-0.008(4.17%) |
Mkt cap ! $83.90M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.3¢ | $59.77K | 338.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 376984 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 25091 | 2 |
View Market Depth
| Last trade - 15.42pm 13/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |